 | • レポートコード：MRC2102QY7992 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のレナリドマイド市場について種類別（5mgカプセル、10mgカプセル、15mgカプセル、25mgカプセル）、用途別（多発性骨髄腫（MM）、骨髄異形成症候群（MDS））、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・レナリドマイド市場の概要 ・世界の主要地域別レナリドマイド市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のレナリドマイド市場規模2015-2026：種類別（5mgカプセル、10mgカプセル、15mgカプセル、25mgカプセル） ・世界のレナリドマイド市場規模2015-2026：用途別（多発性骨髄腫（MM）、骨髄異形成症候群（MDS）） ・レナリドマイドの米国市場規模2015-2020 ・レナリドマイドのヨーロッパ市場規模2015-2020 ・レナリドマイドの中国市場規模2015-2020 ・レナリドマイドの日本市場規模2015-2020 ・レナリドマイドの東南アジア市場規模2015-2020 ・レナリドマイドのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・レナリドマイドの製造コスト分析 ・販売チャネル、流通業者、顧客 ・レナリドマイドの市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Lenalidomide Market
The global Lenalidomide market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Lenalidomide Scope and Market Size
The global Lenalidomide market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lenalidomide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Lenalidomide market is segmented into
5 mg Capsules
10 mg Capsules
15 mg Capsules
25 mg Capsules
Segment by Application, the Lenalidomide market is segmented into
Multiple myeloma (MM)
Myelodysplastic syndromes (MDS)
The Lenalidomide market is analysed and market size information is provided by regions (countries). Segment by Application, the Lenalidomide market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Lenalidomide Market Share Analysis
Lenalidomide market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Lenalidomide business, the date to enter into the Lenalidomide market, Lenalidomide product introduction, recent developments, etc.
The major vendors covered:
Celgene
Exova
1 Lenalidomide Market Overview
1.1 Lenalidomide Product Scope
1.2 Lenalidomide Segment by Type
1.2.1 Global Lenalidomide Sales by Type (2020-2026)
1.2.2 5 mg Capsules
1.2.3 10 mg Capsules
1.2.4 15 mg Capsules
1.2.5 25 mg Capsules
1.3 Lenalidomide Segment by Application
1.3.1 Global Lenalidomide Sales Comparison by Application (2020-2026)
1.3.2 Multiple myeloma (MM)
1.3.3 Myelodysplastic syndromes (MDS)
1.4 Lenalidomide Market Estimates and Forecasts (2015-2026)
1.4.1 Global Lenalidomide Sales Growth Rate (2015-2026)
1.4.2 Global Lenalidomide Revenue and Growth Rate (2015-2026)
1.4.3 Global Lenalidomide Price Trends (2015-2026)
2 Lenalidomide Estimate and Forecast by Region
2.1 Global Lenalidomide Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Lenalidomide Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Lenalidomide Sales Market Share by Region (2015-2020)
2.2.2 Global Lenalidomide Revenue Market Share by Region (2015-2020)
2.3 Global Lenalidomide Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Lenalidomide Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Lenalidomide Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Lenalidomide Estimates and Projections (2015-2026)
2.4.2 Europe Lenalidomide Estimates and Projections (2015-2026)
2.4.3 China Lenalidomide Estimates and Projections (2015-2026)
2.4.4 Japan Lenalidomide Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Lenalidomide Estimates and Projections (2015-2026)
2.4.6 India Lenalidomide Estimates and Projections (2015-2026)
3 Global Lenalidomide Competition Landscape by Players
3.1 Global Top Lenalidomide Players by Sales (2015-2020)
3.2 Global Top Lenalidomide Players by Revenue (2015-2020)
3.3 Global Lenalidomide Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lenalidomide as of 2019)
3.4 Global Lenalidomide Average Price by Company (2015-2020)
3.5 Manufacturers Lenalidomide Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Lenalidomide Players (Opinion Leaders)
4 Global Lenalidomide Market Size by Type
4.1 Global Lenalidomide Historic Market Review by Type (2015-2020)
4.1.1 Global Lenalidomide Sales Market Share by Type (2015-2020)
4.1.2 Global Lenalidomide Revenue Market Share by Type (2015-2020)
4.1.3 Global Lenalidomide Price by Type (2015-2020)
4.2 Global Lenalidomide Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Lenalidomide Sales Forecast by Type (2021-2026)
4.2.2 Global Lenalidomide Revenue Forecast by Type (2021-2026)
4.2.3 Global Lenalidomide Price Forecast by Type (2021-2026)
5 Global Lenalidomide Market Size by Application
5.1 Global Lenalidomide Historic Market Review by Application (2015-2020)
5.1.1 Global Lenalidomide Sales Market Share by Application (2015-2020)
5.1.2 Global Lenalidomide Revenue Market Share by Application (2015-2020)
5.1.3 Global Lenalidomide Price by Application (2015-2020)
5.2 Global Lenalidomide Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Lenalidomide Sales Forecast by Application (2021-2026)
5.2.2 Global Lenalidomide Revenue Forecast by Application (2021-2026)
5.2.3 Global Lenalidomide Price Forecast by Application (2021-2026)
6 United States Lenalidomide Market Facts & Figures
6.1 United States Lenalidomide Sales Market Share by Company (2015-2020)
6.2 United States Lenalidomide Sales Market Share by Type (2015-2020)
6.3 United States Lenalidomide Sales Market Share by Application (2015-2020)
7 Europe Lenalidomide Market Facts & Figures
7.1 Europe Lenalidomide Sales Market Share by Company (2015-2020)
7.2 Europe Lenalidomide Sales Market Share by Type (2015-2020)
7.3 Europe Lenalidomide Sales Market Share by Application (2015-2020)
8 China Lenalidomide Market Facts & Figures
8.1 China Lenalidomide Sales Market Share by Company (2015-2020)
8.2 China Lenalidomide Sales Market Share by Type (2015-2020)
8.3 China Lenalidomide Sales Market Share by Application (2015-2020)
9 Japan Lenalidomide Market Facts & Figures
9.1 Japan Lenalidomide Sales Market Share by Company (3015-3030)
9.2 Japan Lenalidomide Sales Market Share by Type (2015-2020)
9.3 Japan Lenalidomide Sales Market Share by Application (2015-2020)
10 Southeast Asia Lenalidomide Market Facts & Figures
10.1 Southeast Asia Lenalidomide Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Lenalidomide Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Lenalidomide Sales Market Share by Application (2015-2020)
11 India Lenalidomide Market Facts & Figures
11.1 India Lenalidomide Sales Market Share by Company (2015-2020)
11.2 India Lenalidomide Sales Market Share by Type (2015-2020)
11.3 India Lenalidomide Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Lenalidomide Business
12.1 Celgene
12.1.1 Celgene Corporation Information
12.1.2 Celgene Business Overview
12.1.3 Celgene Lenalidomide Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Celgene Lenalidomide Products Offered
12.1.5 Celgene Recent Development
12.2 Exova
12.2.1 Exova Corporation Information
12.2.2 Exova Business Overview
12.2.3 Exova Lenalidomide Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Exova Lenalidomide Products Offered
12.2.5 Exova Recent Development
…
13 Lenalidomide Manufacturing Cost Analysis
13.1 Lenalidomide Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Lenalidomide
13.4 Lenalidomide Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Lenalidomide Distributors List
14.3 Lenalidomide Customers
15 Market Dynamics
15.1 Lenalidomide Market Trends
15.2 Lenalidomide Opportunities and Drivers
15.3 Lenalidomide Market Challenges
15.4 Lenalidomide Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Lenalidomide Sales (K Pcs) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Lenalidomide Sales (K Pcs) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Lenalidomide Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Lenalidomide Sales (K Pcs) by Region (2015-2020)
Table 5. Global Lenalidomide Sales Market Share by Region (2015-2020)
Table 6. Global Lenalidomide Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Lenalidomide Revenue Share by Region (2015-2020)
Table 8. Global Lenalidomide Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Lenalidomide Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Lenalidomide Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Lenalidomide Revenue Share Forecast by Region (2021-2026)
Table 12. Global Lenalidomide (K Pcs) of Key Companies (2015-2020)
Table 13. Global Lenalidomide Sales Share by Company (2015-2020)
Table 14. Global Lenalidomide Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Lenalidomide Revenue Share by Company (2015-2020)
Table 16. Global Lenalidomide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lenalidomide as of 2019)
Table 17. Global Lenalidomide Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Lenalidomide Manufacturing Sites and Area Served
Table 19. Manufacturers Lenalidomide Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Lenalidomide Players
Table 22. Global Lenalidomide Sales (K Pcs) by Type (2015-2020)
Table 23. Global Lenalidomide Sales Share by Type (2015-2020)
Table 24. Global Lenalidomide Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Lenalidomide Price (K Pcs) by Type (2015-2020)
Table 26. Global Lenalidomide Sales Share by Type (2021-2026)
Table 27. Global Lenalidomide Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Lenalidomide Revenue Share by Type (2021-2026)
Table 29. Global Lenalidomide Price (K Pcs) by Type (2021-2026)
Table 30. Global Lenalidomide Sales (K Pcs) by Application (2015-2020)
Table 31. Global Lenalidomide Sales Share by Application (2015-2020)
Table 32. Global Lenalidomide Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Lenalidomide Price (K Pcs) by Application (2015-2020)
Table 34. Global Lenalidomide Sales (K Pcs) by Application (2021-2026)
Table 35. Global Lenalidomide Sales Share by Application (2021-2026)
Table 36. Global Lenalidomide Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Lenalidomide Revenue Share by Application (2021-2026)
Table 38. Global Lenalidomide Price (K Pcs) by Application (2021-2026)
Table 39. United States Lenalidomide Sales (K Pcs) by Company (2015-2020)
Table 40. United States Lenalidomide Sales Market Share by Company (2015-2020)
Table 41. United States Lenalidomide Sales (K Pcs) by Type (2015-2020)
Table 42. United States Lenalidomide Sales Market Share by Type (2015-2020)
Table 43. United States Lenalidomide Sales (K Pcs) by Application (2015-2020)
Table 44. United States Lenalidomide Sales Market Share by Application (2015-2020)
Table 45. Europe Lenalidomide Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Lenalidomide Sales Market Share by Company (2015-2020)
Table 47. Europe Lenalidomide Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Lenalidomide Sales Market Share by Type (2015-2020)
Table 49. Europe Lenalidomide Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Lenalidomide Sales Market Share by Type (2015-2020)
Table 51. China Lenalidomide Sales (K Pcs) by Company (2015-2020)
Table 52. China Lenalidomide Sales Market Share by Company (2015-2020)
Table 53. China Lenalidomide Sales (K Pcs) by Type (2015-2020)
Table 54. China Lenalidomide Sales Market Share by Type (2015-2020)
Table 55. China Lenalidomide Sales (K Pcs) by Application (2015-2020)
Table 56. China Lenalidomide Sales Market Share by Application (2015-2020)
Table 57. Japan Lenalidomide Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Lenalidomide Sales Market Share by Company (2015-2020)
Table 59. Japan Lenalidomide Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Lenalidomide Sales Market Share by Type (2015-2020)
Table 61. Japan Lenalidomide Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Lenalidomide Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Lenalidomide Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Lenalidomide Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Lenalidomide Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Lenalidomide Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Lenalidomide Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Lenalidomide Sales Market Share by Application (2015-2020)
Table 69. India Lenalidomide Sales (K Pcs) by Company (2015-2020)
Table 70. India Lenalidomide Sales Market Share by Company (2015-2020)
Table 71. India Lenalidomide Sales (K Pcs) by Type (2015-2020)
Table 72. India Lenalidomide Sales Market Share by Type (2015-2020)
Table 73. India Lenalidomide Sales (K Pcs) by Application (2015-2020)
Table 74. India Lenalidomide Sales Market Share by Application (2015-2020)
Table 75. Celgene Corporation Information
Table 76. Celgene Description and Business Overview
Table 77. Celgene Lenalidomide Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Celgene Lenalidomide Product
Table 79. Celgene Recent Development
Table 80. Exova Corporation Information
Table 81. Exova Description and Business Overview
Table 82. Exova Lenalidomide Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Exova Lenalidomide Product
Table 84. Exova Recent Development
Table 85. Production Base and Market Concentration Rate of Raw Material
Table 86. Key Suppliers of Raw Materials
Table 87. Lenalidomide Distributors List
Table 88. Lenalidomide Customers List
Table 89. Lenalidomide Market Key Trends
Table 90. Lenalidomide Key Opportunities and Drivers
Table 91. Lenalidomide Market Challenges
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Lenalidomide Product Picture
Figure 2. Global Lenalidomide Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Lenalidomide Market Share by Application in 2020 & 2026
Figure 6. Multiple myeloma (MM) Examples
Figure 7. Myelodysplastic syndromes (MDS) Examples
Figure 8. Global Lenalidomide Sales (K Pcs) Growth Rate (2015-2026)
Figure 9. Global Lenalidomide Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Lenalidomide Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 11. Global Lenalidomide Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Lenalidomide Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Lenalidomide Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Lenalidomide Sales (K Pcs) Growth Rate (2015-2026)
Figure 15. Europe Lenalidomide Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Lenalidomide Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Lenalidomide Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Lenalidomide Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Lenalidomide Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Lenalidomide Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Lenalidomide Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Lenalidomide Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Lenalidomide Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Lenalidomide Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Lenalidomide Players Market Share by Revenue in Lenalidomide 2015 & 2019
Figure 26. Lenalidomide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Lenalidomide Revenue Share by Type (2015-2020)
Figure 28. Global Lenalidomide Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Lenalidomide Revenue Share by Application (2015-2020)
Figure 30. Global Lenalidomide Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Lenalidomide Sales Market Share by Type in 2019
Figure 32. United States Lenalidomide Sales Market Share by Type in 2019
Figure 33. Europe Lenalidomide Sales Market Share by Company in 2019
Figure 34. Europe Lenalidomide Sales Market Share by Type in 2019
Figure 35. Europe Lenalidomide Sales Market Share by Application in 2019
Figure 36. China Lenalidomide Sales Market Share by Company in 2019
Figure 37. China Lenalidomide Sales Market Share by Type in 2019
Figure 38. China Lenalidomide Sales Market Share by Application in 2019
Figure 39. Japan Lenalidomide Sales Market Share by Company in 2019
Figure 40. Japan Lenalidomide Sales Market Share by Type in 2019
Figure 41. Japan Lenalidomide Sales Market Share by Application in 2019
Figure 42. Southeast Asia Lenalidomide Sales Market Share by Company in 2019
Figure 43. Southeast Asia Lenalidomide Sales Market Share by Type in 2019
Figure 44. Southeast Asia Lenalidomide Sales Market Share by Application in 2019
Figure 45. India Lenalidomide Sales Market Share by Company in 2019
Figure 46. India Lenalidomide Sales Market Share by Type in 2019
Figure 47. India Lenalidomide Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Lenalidomide
Figure 50. Manufacturing Process Analysis of Lenalidomide
Figure 51. Lenalidomide Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
野菜カプセルの世界市場レポート2020 Vegetarian capsules are all-natural, GMO free, plant-based shell, free from animal derivatives, gluten, and modified sugars. Nowadays, Vegetarian capsules can be divided into several kinds such as Plant Polysaccharides (Pullulan), Starches, and HPMC (Hydroxyl Propyl Methyl Celluloses). Vegetarian ca…- ベジタリアンカプセルの世界市場レポート2020 Vegetarian capsule is made up of cellulose, an important structural component in plants. Market Analysis and Insights: Global Vegetarian Based Capsules Market The global Vegetarian Based Capsules market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% …
- ベジタリアンソフトジェルカプセルの世界市場レポート2020 Vegetarian Softgel Capsules is a kind of Softgels, a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both. Vegetarian Softgels are all-natural, GMO free, plant-based shell, free from anima…
- コーヒーカプセルの世界市場レポート2020 Market Analysis and Insights: Global Coffee Capsules Market The global Coffee Capsules market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Coffee Capsules Scope and Market Size The global Coffee Capsules market is segmented…
- ゼラチンベースカプセルの世界市場レポート2020 Gelatin based capsules are created through a process where hooves, bones, and connective tissues are boiled down into a gel-like substance, put through a cooling process, and then formed into a capsule. Market Analysis and Insights: Global Gelatin Based Capsules Market The global Gelatin Based Capsu…